|
|
|
|
Дата |
|---|
| 04.04.2025 |
| 03.04.2025 |
| 02.04.2025 |
| 01.04.2025 |
| 31.03.2025 |
| 28.03.2025 |
| 27.03.2025 |
| 26.03.2025 |
| 25.03.2025 |
| 24.03.2025 |
Bid | Ask |
Open |
Min | Max |
Last |
Legal close |
Avg |
Оборот |
Кол-во сделок |
|---|---|---|---|---|---|---|---|
|
|
|
1 994.00
|
1 730.00
|
2 195.00
|
1 918.00
|
|
|
1 315 925 513.00
|
|
|
|
|
2 900.00
|
2 115.00
|
3 125.00
|
2 115.00
|
|
|
1 261 710 425.00
|
|
|
|
|
3 250.00
|
2 990.00
|
3 550.00
|
3 015.00
|
|
|
620 458 066.00
|
|
|
|
|
3 325.00
|
2 915.00
|
3 410.00
|
3 050.00
|
|
|
662 139 015.00
|
|
|
|
|
3 210.00
|
2 900.00
|
3 530.00
|
3 105.00
|
|
|
839 586 901.00
|
|
|
|
|
4 065.00
|
3 505.00
|
4 250.00
|
3 560.00
|
|
|
1 859 306 550.00
|
|
|
|
|
3 100.00
|
3 050.00
|
4 030.00
|
4 030.00
|
|
|
4 264 523 412.00
|
|
|
|
|
4 070.00
|
2 940.00
|
4 365.00
|
3 100.00
|
|
|
3 856 532 954.00
|
|
|
|
|
2 700.00
|
2 700.00
|
3 510.00
|
3 510.00
|
|
|
1 355 373 187.00
|
|
|
|
|
2 685.00
|
2 450.00
|
2 975.00
|
2 700.00
|
|
|
331 055 210.00
|
|
Olipass Corporation operates nucleic acid biotechnology businesses. The Company mainly develops and produces artificial nuclease therapeutic agents. Olipass also researches gene and protein biotechnologies.
